Company Search:
Advanced Search
Sponsored Links
Innovent Biologics Inc Company Snapshot
Innovent Biologics Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Innovent Biologics Inc with three other pharmaceutical manufacturers in Asia: Ensol Biosciences Inc of South Korea (2018 sales of 399.89 million Korean Won [US$336,310.15 ] of which 100% was Pharmaceutical Development and Sales), Syncore Biotechnology Co Ltd of Taiwan (7.71 million Taiwanese Dollars [US$253,296.22 ] ), and Body Organ Biomedical Corp which is also based in Taiwan (24.29 million Taiwanese Dollars [US$798,280.82 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Innovent Biologics Inc
  Stock Performance Chart for Innovent Biologics Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/13/2019): 26.85
(Figures in Hong Kong Dollars)
1 Week -5.5%   13 Weeks 8.7%  
4 Weeks 11.4%   52 Weeks 28.2%  
Innovent Biologics Inc Key Data:
  Ticker: 1801 Country: China
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 11,218,967
(Year Ending Jan 2019).
Employees: 959
  Currency: Hong Kong Dollars Market Cap: 31,109,194,289
  Fiscal Yr Ends: December Shares Outstanding: 1,158,629,210
  Share Type: Ordinary Closely Held Shares: 274,355,513
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.